| 前收市價 | 0.7000 |
| 開市 | 0.9000 |
| 買盤 | 0.6000 |
| 賣出價 | 1.8500 |
| 拍板 | 10.00 |
| 到期日 | 2024-10-18 |
| 今日波幅 | 0.8000 - 0.9000 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 259 |
ZacksVoyager Therapeutics (VYGR) Reports Q1 Loss, Tops Revenue Estimates
Voyager Therapeutics (VYGR) delivered earnings and revenue surprises of 54.55% and 88.87%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
ZacksAgios (AGIO) Q1 Earnings Surpass, Sales Miss Estimates
Agios (AGIO) reports mixed earnings results for first-quarter 2024. Though sales miss the mark, revenues from its sole marketed drug, Pyrukynd, rise sequentially and on a yearly basis.
- Zacks
Jazz (JAZZ) Q1 Earnings & Sales Fall Short of Estimates
Jazz's (JAZZ) first-quarter earnings and sales miss the mark. The company reaffirms its guidance for full-year 2024.
